Shant Laboratories Ltd.

POWER SEARCH PRICING

SOLUTIONS

shant laboratories ltd. Company Information

Live

MatureMicroDeclining

Company Number

03194226

Next Accounts

Feb 2025

Industry

Manufacture of other non-metallic mineral products n.e.c.

Directors

Adrian Radulescu

Shareholders

rock nominees ltd a/c 0710556

jenny spillane & john spillane

View All

Group Structure

View All

Contact

Registered Address

savoy house savoy circus, london, england, W3 7DA

Website

www.shantlabs.com

shant laboratories ltd. Estimated Valuation

£167k

Pomanda estimates the enterprise value of SHANT LABORATORIES LTD. at £167k based on a Turnover of £349.7k and 0.48x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Shant Laboratories Ltd. is a live company located in england, W3 7DA with a Companies House number of 03194226. It operates in the manufacture of other non-metallic mineral products n.e.c. sector, SIC Code 23990. Founded in May 1996, it's largest shareholder is rock nominees ltd a/c 0710556 with a 93.6% stake. Shant Laboratories Ltd. is a mature, micro sized company, Pomanda has estimated its turnover at £349.7k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Shant Laboratories Ltd. a 1 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating1out of 5

0 Strong

3 Regular

7 Weak

Size

annual sales of £349.7k, make it smaller than the average company (£25m)

Growth

3 year (CAGR) sales growth of -1%, show it is growing at a slower rate (7.5%)

EXPORT

Shant Laboratories Ltd.'s latest turnover from May 2023 is estimated at £349.7 thousand and the company has net assets of -£229.6 thousand. According to their latest financial statements, we estimate that Shant Laboratories Ltd. has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	May 2023	May 2022	May 2021	May 2020	May 2019	May 2018	May 2017	May 2016	May 2015	May 2014	May 2013	May 2012	May 2011	May 2010
Turnover	349,737	347,909	294,479	355,761	327,870	285,500	292,821	288,604	411,782	397,356	300,958	264,788	336,175	243,931
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	262,735	258,868	225,023	252,829	231,421	210,093	204,853	198,901	291,931	291,975	229,964	199,153	246,074	168,850
Gross Profit	87,002	89,042	69,456	102,932	96,449	75,407	87,969	89,703	119,851	105,381	70,993	65,635	90,101	75,081
Admin Expenses	71,789	81,181	63,589	97,256	89,921	74,178	87,736	89,337	118,572	104,271	69,995	65,028	176,007	215,767
Operating Profit	15,213	7,861	5,867	5,676	6,528	1,229	233	366	1,279	1,110	998	607	-85,906	-140,686
Interest Payable	20,793	13,509	11,465	11,158	12,006	7,405	3,281	3,413	3,413	3,413	3,413	3,413	1,706	0
Interest Receivable	0	0	0	0	0	0	0	0	0	0	1	1	0	0
Pre-Tax Profit	-5,580	-5,648	-5,598	-5,482	-5,478	-6,176	-3,048	-3,046	-2,133	-2,302	-2,414	-2,805	-87,612	-140,686
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-5,580	-5,648	-5,598	-5,482	-5,478	-6,176	-3,048	-3,046	-2,133	-2,302	-2,414	-2,805	-87,612	-140,686
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-5,580	-5,648	-5,598	-5,482	-5,478	-6,176	-3,048	-3,046	-2,133	-2,302	-2,414	-2,805	-87,612	-140,686
Employee Costs	100,849	91,308	43,397	86,555	85,893	43,425	44,659	43,339	83,430	82,405	40,949	38,687	79,072	34,778
Number Of Employees	2	2	1	2	2	1	1	1	2	2	1	1	2	1
EBITDA*	15,213	7,861	5,867	5,676	6,528	1,229	233	366	1,279	1,110	998	607	-85,638	-140,424

* Earnings Before Interest, Tax, Depreciation and Amortisation

	May 2023	May 2022	May 2021	May 2020	May 2019	May 2018	May 2017	May 2016	May 2015	May 2014	May 2013	May 2012	May 2011	May 2010
Tangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	268
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	268
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	66,254	66,254	66,254	66,254	66,254	66,254	66,254	63,254	60,328	56,064	52,189	48,163	44,121	40,400
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	0	0	0	4	0	0	0	0	0	0	0	0
Cash	0	0	9	7	1	40	32	107	79	20	115	205	124	3
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	66,254	66,254	66,263	66,261	66,255	66,298	66,286	63,361	60,407	56,084	52,304	48,368	44,245	40,403
total assets	66,254	66,254	66,263	66,261	66,255	66,298	66,286	63,361	60,407	56,084	52,304	48,368	44,245	40,671
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	16,155	16,155	16,155	16,155	16,155	16,155	16,155	16,155	89,724	88,308	28,148	28,149	84,068	28,327
Group/Directors Accounts	0	0	0	59,541	59,453	59,377	58,658	62,122	0	0	59,118	57,807	0	52,125
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	79,152	78,612	78,013	17,912	17,552	17,233	16,804	12,407	0	0	0	0	0	0
total current liabilities	95,307	94,767	94,168	93,608	93,160	92,765	91,617	90,684	89,724	88,308	87,266	85,956	84,068	80,452
loans	200,550	195,510	190,470	185,430	180,390	175,350	52,500	52,500	52,500	52,500	52,500	52,500	52,500	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	117,810	112,770	107,730	102,690	97,650	92,610	87,570	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	200,550	195,510	190,470	185,430	180,390	175,350	170,310	165,270	160,230	155,190	150,150	145,110	140,070	0
total liabilities	295,857	290,277	284,638	279,038	273,550	268,115	261,927	255,954	249,954	243,498	237,416	231,066	224,138	80,452
net assets	-229,603	-224,023	-218,375	-212,777	-207,295	-201,817	-195,641	-192,593	-189,547	-187,414	-185,112	-182,698	-179,893	-39,781
total shareholders funds	-229,603	-224,023	-218,375	-212,777	-207,295	-201,817	-195,641	-192,593	-189,547	-187,414	-185,112	-182,698	-179,893	-39,781

	May 2023	May 2022	May 2021	May 2020	May 2019	May 2018	May 2017	May 2016	May 2015	May 2014	May 2013	May 2012	May 2011	May 2010
Operating Activities
Operating Profit	15,213	7,861	5,867	5,676	6,528	1,229	233	366	1,279	1,110	998	607	-85,906	-140,686
Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	268	262
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	0	0	0	0	-4	4	3,000	2,926	4,264	3,875	4,026	4,042	3,721	40,400
Creditors	0	0	0	0	0	0	0	-73,569	1,416	60,160	-1	-55,919	55,741	28,327
Accruals and Deferred Income	540	599	60,101	360	319	429	4,397	12,407	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	15,753	8,460	65,968	6,036	6,851	1,654	1,630	-63,722	-1,569	57,395	-3,029	-59,354	-33,618	-152,497
Investing Activities
capital expenditure	0	0	0	0	0	0	0	0	0	0	0	0	0	-530
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	0	0	0	0	0	0	0	0	0	0	0	0	0	-530
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	-59,541	88	76	719	-3,464	62,122	0	-59,118	1,311	57,807	-52,125	52,125
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	5,040	5,040	5,040	5,040	5,040	122,850	0	0	0	0	0	0	52,500	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	-117,810	5,040	5,040	5,040	5,040	5,040	5,040	87,570	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	-52,500	100,905
interest	-20,793	-13,509	-11,465	-11,158	-12,006	-7,405	-3,281	-3,413	-3,413	-3,413	-3,412	-3,412	-1,706	0
cash flow from financing	-15,753	-8,469	-65,966	-6,030	-6,890	-1,646	-1,705	63,749	1,627	-57,491	2,939	59,435	33,739	153,030
cash and cash equivalents
cash	0	-9	2	6	-39	8	-75	28	59	-95	-90	81	121	3
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	0	-9	2	6	-39	8	-75	28	59	-95	-90	81	121	3

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for shant laboratories ltd.. Get real-time insights into shant laboratories ltd.'s credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for shant laboratories ltd. by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in W 3 area or any other competitors across 12 key performance metrics.

SHANT LABORATORIES LTD. group structure

Shant Laboratories Ltd. has no subsidiary companies.

Ultimate parent company

SHANT LABORATORIES LTD.

03194226

SHANT LABORATORIES LTD. Shareholders

rock nominees ltd a/c 0710556	93.64%
jenny spillane & john spillane	4.67%
shant international ltd	1.65%
bankhill trustees ltd	0.02%
mrs jenny spillane & mr john spillane	0.01%

Shant Laboratories Ltd. currently has 1 director, Dr Adrian Radulescu serving since Jun 1996.

officer	country	age	start	end	role
Dr Adrian Radulescu	United Kingdom	62 years	Jun 1996	-	Director

P&L

May 2023

turnover

349.7k

+1%

operating profit

15.2k

gross margin

24.9%

-2.8%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

May 2023

net assets

-229.6k

+0.02%

total assets

66.3k

cash

net assets

Total assets minus all liabilities

Similar Companies

metssl limited

pure klenz limited

artificial stone company limited

4.5

dittoki limited

save the carbon limited

company number

03194226

Type

Private limited with Share Capital

industry

23990 - Manufacture of other non-metallic mineral products n.e.c.

incorporation date

May 1996

ultimate parent company

None

previous names

shant advanced biotechnologies limited (October 1997)

law 736 limited (June 1996)

address

savoy house savoy circus, london, england, W3 7DA

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to shant laboratories ltd..

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for SHANT LABORATORIES LTD.. This can take several minutes, an email will notify you when this has completed.

shant laboratories ltd. Company Information

shant laboratories ltd. Estimated Valuation

shant laboratories ltd. Estimated Valuation

shant laboratories ltd. Estimated Valuation

Shant Laboratories Ltd. Overview

Shant Laboratories Ltd. Health Check

SHANT LABORATORIES LTD. financials

shant laboratories ltd. Credit Report and Business Information

Shant Laboratories Ltd. Competitor Analysis

shant laboratories ltd. Ownership

shant laboratories ltd. directors

shant laboratories ltd. company details

shant laboratories ltd. Charges & Mortgages

shant laboratories ltd. Capital Raised & Share Issues BETA

shant laboratories ltd. Companies House Filings - See Documents